CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences operating margin
Operating margin is operating income as a percentage of revenue.
CV Sciences's operating margin for the twelve months ending Sep 30, 2026 was -2.5%. For fiscal 2025 it was -3.4%, against -13.9% the year before. The highest annual figure on record is 21.2% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3.4% | +10.5 |
| FY2024 | Dec 31, 2024 | -13.9% | −34.9 |
| FY2023 | Dec 31, 2023 | 21.0% | +63.2 |
| FY2022 | Dec 31, 2022 | -42.3% | +49.8 |
| FY2021 | Dec 31, 2021 | -92.0% | +0.5 |
| FY2020 | Dec 31, 2020 | -92.5% | −60.4 |
| FY2019 | Dec 31, 2019 | -32.1% | −53.3 |
| FY2018 | Dec 31, 2018 | 21.2% | +44.7 |
| FY2017 | Dec 31, 2017 | -23.5% | +94.7 |
| FY2016 | Dec 31, 2016 | -118.2% | −21.0 |
| FY2015 | Dec 31, 2015 | -97.2% | −13.3 |
| FY2014 | Dec 31, 2014 | -83.9% | −8.8 |
| FY2013 | Dec 31, 2013 | -75.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 12.5% | +20.9 |
| Q2 FY2026 | Jun 30, 2026 | -10.1% | −6.5 |
| Q1 FY2026 | Mar 31, 2026 | -10.0% | −10.3 |
| Q4 FY2025 | Dec 31, 2025 | -2.3% | +14.4 |
| Q3 FY2025 | Sep 30, 2025 | -8.4% | +0.4 |
| Q2 FY2025 | Jun 30, 2025 | -3.6% | +11.1 |
| Q1 FY2025 | Mar 31, 2025 | 0.3% | +15.8 |
| Q4 FY2024 | Dec 31, 2024 | -16.6% | +6.8 |
| Q3 FY2024 | Sep 30, 2024 | -8.8% | +1.9 |
| Q2 FY2024 | Jun 30, 2024 | -14.7% | +12.4 |
| Q1 FY2024 | Mar 31, 2024 | -15.5% | −154.4 |
| Q4 FY2023 | Dec 31, 2023 | -23.4% | +31.5 |
| Q3 FY2023 | Sep 30, 2023 | -10.7% | +13.1 |
| Q2 FY2023 | Jun 30, 2023 | -27.1% | +28.8 |
| Q1 FY2023 | Mar 31, 2023 | 138.9% | +173.0 |
| Q4 FY2022 | Dec 31, 2022 | -54.9% | +123.0 |
| Q3 FY2022 | Sep 30, 2022 | -23.8% | +34.6 |
| Q2 FY2022 | Jun 30, 2022 | -55.9% | +12.5 |
| Q1 FY2022 | Mar 31, 2022 | -34.1% | +30.2 |
| Q4 FY2021 | Dec 31, 2021 | -178.0% | +4.1 |
| Q3 FY2021 | Sep 30, 2021 | -58.4% | −1.7 |
| Q2 FY2021 | Jun 30, 2021 | -68.4% | +17.9 |
| Q1 FY2021 | Mar 31, 2021 | -64.3% | +0.1 |
| Q4 FY2020 | Dec 31, 2020 | -182.0% | −103.3 |
| Q3 FY2020 | Sep 30, 2020 | -56.6% | −42.6 |
| Q2 FY2020 | Jun 30, 2020 | -86.3% | −93.7 |
| Q1 FY2020 | Mar 31, 2020 | -64.3% | −1.4 |
| Q4 FY2019 | Dec 31, 2019 | -78.7% | −98.1 |
| Q3 FY2019 | Sep 30, 2019 | -14.1% | −40.0 |
| Q2 FY2019 | Jun 30, 2019 | 7.4% | −19.3 |
| Q1 FY2019 | Mar 31, 2019 | -62.9% | −71.2 |
| Q4 FY2018 | Dec 31, 2018 | 19.4% | +17.5 |
| Q3 FY2018 | Sep 30, 2018 | 25.9% | +34.5 |
| Q2 FY2018 | Jun 30, 2018 | 26.7% | +47.8 |
| Q1 FY2018 | Mar 31, 2018 | 8.3% | +105.3 |
| Q4 FY2017 | Dec 31, 2017 | 1.9% | +258.1 |
| Q3 FY2017 | Sep 30, 2017 | -8.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -21.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -97.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -256.2% | – |
See a number that looks wrong?